Raycaster
Raycaster provides an AI-native document workspace that helps biopharma companies accelerate commercial wins, R&D, and intellectual property work. The platform uses AI agents and natural language understanding to extract insights from documents and data—supporting tasks like surfacing purchase-ready accounts, automating RFP responses, analyzing clinical trials, and monitoring patent landscapes. It is positioned as a B2B SaaS product for biopharma providers and instrument makers, integrating with commercial and regulatory workflows and common enterprise tools. Raycaster’s core technologies include large language models for document understanding and analytics focused on IP intelligence, competitive analysis, and lab/instrument specifications.
Raycaster
Raycaster provides an AI-native document workspace that helps biopharma companies accelerate commercial wins, R&D, and intellectual property work. The platform uses AI agents and natural language understanding to extract insights from documents and data—supporting tasks like surfacing purchase-ready accounts, automating RFP responses, analyzing clinical trials, and monitoring patent landscapes. It is positioned as a B2B SaaS product for biopharma providers and instrument makers, integrating with commercial and regulatory workflows and common enterprise tools. Raycaster’s core technologies include large language models for document understanding and analytics focused on IP intelligence, competitive analysis, and lab/instrument specifications.
TL;DR
Company: Raycaster (legal name: 7th Ave Labs, Inc.) — AI-native document/workspace for life sciences and biopharma
Founded: 2024
Headcount: 4 employees (profileed count)
Funding: Pre-Seed (Dec 4, 2024) — investors: Y Combinator, SAV (Scale Asia Ventures)
Product focus: Evidence-backed research, document understanding, IP intelligence, commercial & regulatory workflows
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Life sciences / biopharma document and research workflows including IP intelligence, competitive analysis, and lab/instrument specification discovery.
Founded
2024
Industry
Biotechnology
Tech Stack
Funding Track Record
500000
Investors listed: Y Combinator and SAV (Scale Asia Ventures)
Investor Signal
“YC-backed (Y Combinator lead) and SAV (Scale Asia Ventures)”